October 5, 2023 | Issue #71

Hi... How are you sleeping? (Anyone using a sleep tracker?)

In this week's newsletter:😴 Sleep & Longevity Connection 💰 Mogrify Raises Big🌐 Marky Mark Pushes Longevity   📉 Longevity Stock Index Hits ATL, Again

Constructive Snoozing: The Connection Between Sleep & Longevity

We aren’t sleeping enough, and it’s hurting our species. Despite sleep being widely known as a key to health, many of us still struggle to get the optimum quantity and quality of sleep.Whether because of daily stress, an abundance of engaging digital content captivating us, or simply having too much to do without enough hours in the day, the result is apparent. Why do we still struggle to practice good sleep hygiene despite knowing about the effects on our health and well-being?For many, the short-term pleasure of watching one more show, or reading one more article on your phone outweighs the perceived low-level impacts of grogginess or brain fog the following day. Find out how sleep impacts your longevity and what you can do about it...

Are you joining us in Miami?

Confirmed speakers for Wonderland Miami include:

• Cody Shirk, Founder/CEO, Spannr

• Stephanie Dainow, Executive Director, Lifespan.io

• Aubrey de Grey, Ph.D., President and CSO, LEV Foundation

• Dr. Matthias Breugelmans, CEO at Elastrin Therapeutics Inc.

• Phil Newman, Editor in Chief, Longevity.Technology

• Dr. Halland Chen, The Longevity Doctor

• J. Scotch McClure, CEO & Chairman Maxwell Biosciences, Inc.

• Bryan Johnson, Founder/CEO Blueprint, Kernel & OS Fund

Register today using this link to get 20% off your ticket, or use "SPANNR20" at checkout. 

• Regeneron is hiring for hundreds of positions VIEW HERE.

• Browse thousands of jobs in the longevity industry, updated daily, in Spannr's new Jobs database HERE. 

• Mogrify Limited a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced an additional $10 million USD closing of its Series A financing, bringing the total raised to $46 million USD in this round. The funding will support further advancement of Mogrify’s pipeline of in vivo reprogramming therapies through pre-clinical translation, continued platform optimization, and facilitation of new and existing biopharma collaborations.

• Explore Spannr's Longevity Investor database HERE.

• Is Cardio Fitness or Muscular Strength More Important for Longevity? (GQ)

• New Yale Initiative Looks Beyond Life Span to Increase Years of Health (Yale)

• Duke University Sued Over Lifespan Data Backing Pension Math (Bloomberg)

• "Blue zones" have captivated health and longevity experts. But are they real or statistical grift? (Salon)

• How Your Afternoon Naps Can Affect Your Lifespan (Newsweek)

• Blue zones—where people live the longest—prove you’re only as healthy as those you’re surrounded by. Here’s why (Fortune)

• Mark Wahlberg Says He Used to Work Out for ‘Aesthetic,’ but ‘Now It’s More About Longevity’ (People)

• Jeff Bezos, Mark Zuckerberg And Sam Altman Among The Billionaires Investing In Anti-Aging Technology. Who Else Wants To Live Forever? (Benzinga)

• Forget wonder drugs — here are the cheap, effective anti-aging hacks a billionaire longevity investor swears by (Insider)

Performance:

Latest Price: $84.027d-Return: -9.9%Market Cap: $8.6b

Big Movers:Capricor (CAPR): -50.85%Athersys (ATHX): 30.30%Unity (UBX): -24.48%

ABOUT SPANNR

We are dedicated to helping people understand the biggest business and health story of all time: the unprecedented transformation of society that will result from extending human healthspan and lifespan.

If you have any questions about Spannr or want to get to know us better, 

contact us

 – we'd love to hear from you. We appreciate your interest in what we are creating.